Back
Cartesian Therapeutics Stock Price Chart
U.S. Government Report Alert Tuesday
Discover the Secret Loophole
Buy
70
RNAC
Cartesian Therapeutics
Last Price:
16.94
Seasonality Move:
10.73%
7 Day Trial
ALL ACCESS PASS
$
7
Yours Free! Top SIX AI Dividend Stocks Right Now
NO CREDIT CARD REQUIRED!- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RNAC is experiencing slight selling pressure.
Cartesian Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 20.04 | Sell |
| 20-day SMA: | 21.13 | Sell |
| 50-day SMA: | 18.79 | Buy |
| 200-day SMA: | 20.16 | Sell |
| 8-day EMA: | 20.4 | Sell |
| 20-day EMA: | 20.55 | Sell |
| 50-day EMA: | 19.57 | Buy |
| 200-day EMA: | 21.28 | Sell |
Cartesian Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.17 | Buy |
| Relative Strength Index (14 RSI): | 46.9 | Sell |
| Chaikin Money Flow: | -46344 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (20.17 - 22.57) | Sell |
| Bollinger Bands (100): | (14.27 - 21.53) | Buy |
Cartesian Therapeutics Technical Analysis
| Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Cartesian Therapeutics Stock
Is Cartesian Therapeutics Stock a Buy?
- Cartesian Therapeutics share price is 19.78 while RNAC 8-day simple moving average is 20.04, which is a Sell signal.
- The stock price of RNAC is 19.78 while Cartesian Therapeutics 20-day SMA is 21.13, which makes it a Sell.
- Cartesian Therapeutics 50-day simple moving average is 18.79 while RNAC share price is 19.78, making it a Buy technically.
- RNAC stock price is 19.78 and Cartesian Therapeutics 200-day simple moving average is 20.16, creating a Sell signal.
RNAC Technical Analysis vs Fundamental Analysis
Buy
70
Cartesian Therapeutics (RNAC)
is a Buy
Is Cartesian Therapeutics a Buy or a Sell?
-
Cartesian Therapeutics stock is rated a Buy
The current Cartesian Therapeutics [RNAC] share price is $19.78. The Score for RNAC is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
Cartesian Therapeutics Stock Info
Market Cap:
472.67M
Price in USD:
19.78
Share Volume:
117.54K
Cartesian Therapeutics 52-Week Range
52-Week High:
42.60
52-Week Low:
11.67
Buy
70
Cartesian Therapeutics (RNAC)
is a Buy
Cartesian Therapeutics Share Price Forecast
-
What is the Cartesian Therapeutics stock price today?
The Cartesian Therapeutics stock price is 19.78 USD today. -
Will RNAC stock go up or go down?
Cartesian Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Cartesian Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Cartesian Therapeutics is not overvalued.
Is Cartesian Therapeutics Stock a Buy?
- Cartesian Therapeutics share price is 19.78 while RNAC 8-day exponential moving average is 20.40, which is a Sell signal.
- The stock price of RNAC is 19.78 while Cartesian Therapeutics 20-day EMA is 20.55, which makes it a Sell.
- Cartesian Therapeutics 50-day exponential moving average is 19.57 while RNAC share price is 19.78, making it a Buy technically.
- RNAC stock price is 19.78 and Cartesian Therapeutics 200-day simple moving average is 21.28, creating a Sell signal.
Fundamental Analysis of Cartesian Therapeutics
Is Cartesian Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.90 per share, and an increase next year of $1.70 per share.
Technical Analysis of Cartesian Therapeutics
Should I short Cartesian Therapeutics stock?
- RNAC Moving Average Covergence Divergence (MACD) indicator is 0.18, suggesting Cartesian Therapeutics is a Buy
- Cartesian Therapeutics Relative Strength Index (RSI) is 46.9, which suggest Cartesian Therapeutics is oversold
- The Bollinger Bands (25) for Cartesian Therapeutics is (20.17 - 22.57), which suggest Cartesian Therapeutics is a Buy
- The Bollinger Bands (100) for Cartesian Therapeutics is (14.27 - 21.53), which suggest Cartesian Therapeutics is a Buy
* Cartesian Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.